Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1951 4
1952 4
1953 4
1954 4
1955 2
1956 3
1957 5
1958 2
1959 2
1960 2
1961 4
1962 2
1963 3
1965 4
1966 1
1967 1
1968 2
1969 3
1970 3
1971 6
1972 5
1973 7
1974 15
1975 16
1976 16
1977 10
1978 13
1979 6
1980 11
1981 10
1982 12
1983 7
1984 14
1985 8
1986 14
1987 8
1988 19
1989 8
1990 14
1991 9
1992 7
1993 4
1994 5
1995 12
1996 11
1997 10
1998 8
1999 9
2000 6
2001 7
2002 7
2003 8
2004 9
2005 13
2006 22
2007 21
2008 29
2009 28
2010 25
2011 39
2012 35
2013 37
2014 59
2015 48
2016 56
2017 70
2018 52
2019 66
2020 101
2021 122
2022 115
Text availability
Article attribute
Article type
Publication date

Search Results

1,195 results
Results by year
Filters applied: . Clear all
Page 1
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, Tagawa ST, Nordquist LT, Vaishampayan N, El-Haddad G, Park CH, Beer TM, Armour A, Pérez-Contreras WJ, DeSilvio M, Kpamegan E, Gericke G, Messmann RA, Morris MJ, Krause BJ; VISION Investigators. Sartor O, et al. Among authors: herrmann k. N Engl J Med. 2021 Sep 16;385(12):1091-1103. doi: 10.1056/NEJMoa2107322. Epub 2021 Jun 23. N Engl J Med. 2021. PMID: 34161051 Free PMC article. Clinical Trial.
Radiotheranostics: a roadmap for future development.
Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, Gambhir SS, Hricak H, Weissleder R. Herrmann K, et al. Lancet Oncol. 2020 Mar;21(3):e146-e156. doi: 10.1016/S1470-2045(19)30821-6. Lancet Oncol. 2020. PMID: 32135118 Free PMC article. Review.
177Lu-PSMA Radioligand Therapy for Prostate Cancer.
Fendler WP, Rahbar K, Herrmann K, Kratochwil C, Eiber M. Fendler WP, et al. Among authors: herrmann k. J Nucl Med. 2017 Aug;58(8):1196-1200. doi: 10.2967/jnumed.117.191023. Epub 2017 Jun 29. J Nucl Med. 2017. PMID: 28663195 Free article. Review.
PSMA Ligands for PET Imaging of Prostate Cancer.
Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, Afshar-Oromieh A, Herrmann K, Eiber M. Schwarzenboeck SM, et al. Among authors: herrmann k. J Nucl Med. 2017 Oct;58(10):1545-1552. doi: 10.2967/jnumed.117.191031. Epub 2017 Jul 7. J Nucl Med. 2017. PMID: 28687599 Free article. Review.
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kabasakal L, Kaltsas G, Lewington V, Minozzi S, Cinquini M, Öberg K, Oyen WJG, O'Toole D, Pavel M, Ruszniewski P, Scarpa A, Strosberg J, Sundin A, Taïeb D, Virgolini I, Wild D, Herrmann K, Yao J. Ambrosini V, et al. Among authors: herrmann k. Eur J Cancer. 2021 Mar;146:56-73. doi: 10.1016/j.ejca.2021.01.008. Epub 2021 Feb 12. Eur J Cancer. 2021. PMID: 33588146 Free PMC article. Review.
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET.
Ceci F, Oprea-Lager DE, Emmett L, Adam JA, Bomanji J, Czernin J, Eiber M, Haberkorn U, Hofman MS, Hope TA, Kumar R, Rowe SP, Schwarzenboeck SM, Fanti S, Herrmann K. Ceci F, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1626-1638. doi: 10.1007/s00259-021-05245-y. Epub 2021 Feb 19. Eur J Nucl Med Mol Imaging. 2021. PMID: 33604691 Free PMC article.
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K. Kratochwil C, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544. doi: 10.1007/s00259-019-04485-3. Epub 2019 Aug 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 31440799
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer.
Fanti S, Goffin K, Hadaschik BA, Herrmann K, Maurer T, MacLennan S, Oprea-Lager DE, Oyen WJ, Rouvière O, Mottet N, Bjartell A. Fanti S, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):469-476. doi: 10.1007/s00259-020-04934-4. Epub 2020 Jul 2. Eur J Nucl Med Mol Imaging. 2021. PMID: 32617640 Free PMC article.
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, Reiter RE, Holden S, Herrmann K, Zhu S, Fendler WP, Czernin J, Calais J. Hope TA, et al. Among authors: herrmann k. JAMA Oncol. 2021 Nov 1;7(11):1635-1642. doi: 10.1001/jamaoncol.2021.3771. JAMA Oncol. 2021. PMID: 34529005 Free PMC article. Clinical Trial.
The Future of Nuclear Medicine, Molecular Imaging, and Theranostics.
Weber WA, Czernin J, Anderson CJ, Badawi RD, Barthel H, Bengel F, Bodei L, Buvat I, DiCarli M, Graham MM, Grimm J, Herrmann K, Kostakoglu L, Lewis JS, Mankoff DA, Peterson TE, Schelbert H, Schöder H, Siegel BA, Strauss HW. Weber WA, et al. Among authors: herrmann k. J Nucl Med. 2020 Dec;61(Suppl 2):263S-272S. doi: 10.2967/jnumed.120.254532. J Nucl Med. 2020. PMID: 33293447 Free article. Review. No abstract available.
1,195 results